82 results
S-3
FATE
Fate Therapeutics Inc
1 Oct 14
Shelf registration
12:00am
by the affirmative vote of a majority of our directors then in office even if less than a quorum.
No Written Consent of Stockholders. Our certificate … that only a majority of the members of our board of directors then in office may call special meetings of stockholders and only those matters set forth
424B3
zv9pi2 3q
25 Jan 17
Prospectus supplement
12:00am
8-K
EX-10.1
yl8aiee 77uvyrd
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
S-3ASR
uxqgd j5tfnnd
4 Nov 21
Automatic shelf registration
4:56pm
S-3ASR
cpswnm1
21 Nov 18
Automatic shelf registration
4:06pm
424B5
zbpsa ijykvzci8narpc
20 Mar 24
Prospectus supplement for primary offering
5:30pm
424B5
uwokhs2
20 Sep 18
Prospectus supplement for primary offering
4:24pm
424B5
pbpz xalaoksxg4r
21 Sep 18
Prospectus supplement for primary offering
4:41pm
424B5
9kojoo6o8d
11 Sep 19
Prospectus supplement for primary offering
4:08pm